Carolyn F. Deacon

Carolyn F. Deacon

Associate Professor


  1. Published

    Immunoassays for the incretin hormones GIP and GLP-1

    Deacon, Carolyn F. & Holst, Jens Juul, 2009, In : Best Practice & Research: Clinical Endocrinology & Metabolism. 23, 4, p. 425-32 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    MK-431 (Merck).

    Deacon, Carolyn F., 2005, In : Current Opinion in Investigational Drugs. 6, 4, p. 419-26 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes.

    Deacon, Carolyn F., 2007, In : Expert Opinion on Investigational Drugs. 16, 4, p. 533-45 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

    Deacon, Carolyn F. & Holst, Jens Juul, Jan 2010, In : Expert Opinion on Investigational Drugs. 19, 1, p. 133-40 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: A comparative review

    Deacon, Carolyn F., Jan 2011, In : Diabetes, Obesity and Metabolism. 13, 1, p. 7-18 12 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes (vol 10, 80, 2019)

    Deacon, Carolyn F., 3 May 2019, In : Frontiers in Endocrinology. 10, 2 p., 275.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Circulation and degradation of GIP and GLP-1

    Deacon, Carolyn F., 2004, In : Hormone and Metabolic Research. 36, p. 761-765

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

    Deacon, Carolyn F. & Holst, Jens Juul, 2010, In : Expert Opinion on Investigational Drugs. 19, 1, p. 133-140 8 p.

    Research output: Contribution to journalReviewResearchpeer-review

  9. Published

    A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomised controlled trials

    Deacon, Carolyn F., 2018, In : Diabetes, Obesity and Metabolism. 20, Suppl. 1, p. 34-46

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus

    Deacon, Carolyn F., 2020, In : Nature Reviews Endocrinology. 16, 11, p. 642-653

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...23 Next

ID: 9220